Form 4: Hippo Holdings Director Sam Landman Boosts Stake Through RSU Vesting and New Grant
Insider Transaction Report
Hippo Holdings Inc. Director Sam Landman reported an increase in his beneficial ownership of company common stock and restricted stock units following the vesting of previously granted RSUs and the acquisition of new RSUs.
Summary
- Sam Landman, a Director of Hippo Holdings Inc. (HIPO), reported changes in his beneficial ownership of the company's securities.
- On June 3, 2025, 5,801 Restricted Stock Units (RSUs) originally granted on June 4, 2024, vested and settled into common stock.
- These 5,801 shares were valued at $24.35 per share upon vesting, totaling approximately $141,124.35.
- Following this transaction, Sam Landman directly beneficially owned 19,534 shares of common stock.
- Additionally, on June 3, 2025, Mr. Landman acquired 4,738 new Restricted Stock Units (RSUs) at a price of $0.00, which entitle him to receive one share of common stock per RSU upon vesting.
- These new RSUs will vest in full upon the earlier of the first anniversary of the grant date or immediately prior to the Annual Meeting following the grant date, subject to continued service.
- After both transactions, Mr. Landman's total beneficial ownership stands at 24,272 securities, which includes the 4,738 unvested RSUs.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as a director is increasing their stake in the company through RSU vesting and a new grant, aligning their interests with shareholders. This is a routine compensation event.
Positives
- The vesting of 5,801 RSUs demonstrates a conversion of previously earned equity compensation into direct common stock ownership, increasing the director's direct stake.
- The grant of an additional 4,738 RSUs indicates continued equity-based compensation for the director, aligning his interests with long-term shareholder value.
Risks
- No new specific company risks were identified in this Form 4 filing, as it primarily reports insider transactions.
Future Outlook
The 4,738 newly acquired Restricted Stock Units (RSUs) are scheduled to vest in full upon the earlier of the first anniversary of their grant date or immediately prior to the Annual Meeting that occurs following the grant date, contingent on the reporting person's continued service to the Issuer.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity, specifically related to equity compensation. It does not provide broader industry context or trends.
Related Party Transactions
- The vesting and settlement of 5,801 Restricted Stock Units (RSUs) and the grant of 4,738 new RSUs to Director Sam Landman constitute related party dealings as they involve equity compensation from the company to an insider.
Stakeholder Impact
- Shareholders: Provides transparency regarding director equity ownership and compensation, indicating alignment of interests through equity holdings.
Next Steps
- Future vesting of the 4,738 Restricted Stock Units (RSUs) will occur upon the earlier of the first anniversary of the grant date or immediately prior to the Annual Meeting following the grant date.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Original grant date for 5,801 Restricted Stock Units (RSUs) to Sam Landman. |
| 06/03/2025 | Date of transaction, including the vesting and settlement of 5,801 RSUs into Common Stock and the acquisition of 4,738 new Restricted Stock Units (RSUs). |
| 06/04/2025 | Date the Form 4 was filed with the SEC. |
Keywords
Hippo Holdings Inc., HIPO, Sam Landman, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Common Stock, Beneficial Ownership, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.